Researchers investigated how increased cholesterol production in stem cells from people with PMS may contribute to nerve damage. They found using a cholesterol-lowering drug could reduce harmful effects, suggesting a potential new treatment approach for PMS.
Results from the D-Lay MS study, presented at ECTRIMS 2024, appeared to offer contrasting findings to PrevANZ, yet both reinforce the shared message that vitamin D, while potentially beneficial for overall health, is not a standalone treatment for MS.
CEO Rohan Greenland asks whether the Australian Government is doing enough to support MS research and neurological research more generally.
Researchers explore how an evidence-based, co-designed, digital nutrition education program empowers people with MS to make positive changes to their diet.
As bushfire and heatwave season approaches, MS Australia-supported researchers, in partnership with Australian Red Cross, have created new crisis plan resources to help the MS community prepare for emergencies using Australian Red Cross award-winning emergency RediPlan.
The prevalence of MS is increasing in Australia nationally as well as in individual states and territories. This has implications for the resources needed to prevent, treat and manage MS.
CEO Rohan Greenland discusses the announcement of a new Aged Care Bill, which has many welcome changes for people living with disability and includes a long overdue ‘statement of rights’ for older people.
Researchers supported by MS Australia have found that low intensity repetitive transcranial magnetic stimulation enhances myelin repair in preclinical models of MS.
Survey highlights Australian expertise and training priorities in delivering telehealth exercise for MS.
